In short. An autoimmune attack on the hair follicle: the patchy and total forms, the unpredictable course, and the treatment classes used to settle it.

Key points

  • Cosmetically acceptable regrowth rather than a cure.
  • Treatment is judged at six to twelve months.
  • Because relapse is common, some form of maintenance is often needed, and the decision to stop is made with the clinician rather than at the first sign of improvement.

Alopecia areata is an autoimmune condition in which the immune system attacks the hair follicle. It is not caused by stress, diet or a bad shampoo, and it is not infectious. The follicle is inflamed rather than destroyed, which is why regrowth is possible even after years, and why the condition is classified as non-scarring. It affects children and adults, men and women, and it is more common in people who already have another autoimmune condition such as thyroid disease, or a family history of one.

What it looks like

The classic form is one or more smooth, round patches of hair loss with a normal-looking scalp and no scaling. At the edge of an active patch, short tapering hairs that narrow towards the root are visible under magnification, along with hairs that break off. Fine pitting of the fingernails occurs in a minority. The patchy form is by far the most common. When the whole scalp is involved it is called totalis, and when body hair is lost as well it is called universalis; these forms are much less common and much harder to treat. A band of loss around the hairline and nape, called ophiasis, is also recognised.

The course is genuinely unpredictable

This is the part patients find hardest. Patches may regrow spontaneously within a year, may persist, may spread, and may recur after years of stability. Nothing about the size or number of patches reliably predicts what will happen next. Extensive, longstanding and childhood-onset disease tends to be more persistent, and nail involvement is a marker of more extensive disease, but the individual course cannot be forecast with confidence.

Treatment classes

For small patches, treatment is often topical or injected corticosteroids delivered into the affected skin, which settle the local immune attack and are usually well tolerated, with skin thinning as the main limitation of repeated use. For more extensive disease, options include topical immunotherapy designed to redirect the immune response, and systemic immune-modulating agents including the Janus kinase inhibitor class, which has changed what is achievable in severe disease but carries monitoring requirements and a high rate of relapse when stopped. Topical minoxidil is sometimes used alongside these to support regrowth rather than to treat the immune process.

What realistic success looks like

Cosmetically acceptable regrowth rather than a cure. Treatment is judged at six to twelve months. Because relapse is common, some form of maintenance is often needed, and the decision to stop is made with the clinician rather than at the first sign of improvement.

Wigs, hairpieces and scalp camouflage are not a failure of treatment. For extensive disease, a well-fitted medical wig is a legitimate and often transformative part of care, and it can be used alongside treatment rather than instead of it.

Seek assessment promptly if

  • Hair loss is sudden and patchy, especially with scalp redness, scaling or tenderness.
  • Eyebrows, eyelashes or body hair are affected, which suggests a more extensive form.
  • Loss comes with fever, joint pain, mouth ulcers, or a rash elsewhere on the body.

Related reading

Frequently asked questions

Is alopecia areata caused by stress or diet?

No. It is an autoimmune condition in which the immune system attacks the hair follicle, and it is not infectious. The follicle is inflamed rather than destroyed, which is why regrowth is possible even after years and why it is classified as non-scarring.

Will my patches grow back on their own?

Sometimes. Patches may regrow spontaneously within a year, may persist, may spread, and may recur after years of stability. Nothing about the size or number of patches reliably predicts what happens next, which is the part patients find hardest.

What does successful treatment look like?

Cosmetically acceptable regrowth rather than a cure. Treatment is judged at six to twelve months, relapse is common, and some form of maintenance is often needed. The decision to stop is made with the clinician rather than at the first sign of improvement.

Risks & Limitations

  • Most hair loss is progressive and managed rather than reversed; treatment holds the line more often than it restores it.
  • Treatment takes 6–12 months before a response can be judged fairly, and must usually be continued indefinitely to keep the result.
  • Stopping treatment commonly means losing the hair that was regained, usually within months.
  • Some oral agents cause sexual, mood and metabolic side effects, and several require blood monitoring, blood-pressure monitoring, or pregnancy prevention.
  • Hair transplantation moves existing hair; it does not create new hair and does not stop the underlying process.
  • Scarring alopecia destroys the follicle permanently, so hair lost before treatment begins cannot be recovered.
  • No treatment works for everyone, and response cannot be predicted with certainty.

When to Seek Care

  • Sudden patchy hair loss, especially with scalp redness, scaling, itching or pain.
  • Hair loss with fever, joint pain, mouth ulcers, or a rash elsewhere on the body.
  • Scarring changes: an area of scalp that has become smooth, shiny or pale, with loss of the follicular openings.
  • Eyebrow or eyelash loss, which suggests a more extensive or systemic process.
  • Hair loss with fatigue, palpitations, weight change, or heavy or irregular periods — a systemic cause needs excluding.

References & Further Reading

  • American Academy of Dermatology (AAD) — public and clinical guidance on hair and scalp disorders
  • Chinese Medical Association, Dermatology Branch — clinical guidance
  • Cochrane Library — systematic reviews in dermatology
  • World Health Organization (WHO) — general health and nutrition resources

Medically reviewed by Yongbo Jia, MD (贾勇波), Deputy Director & Head of Dermatology. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.